Literature DB >> 10851114

Permeation through the CFTR chloride channel.

N A McCarty1.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) protein forms a Cl(-) channel found in the plasma membranes of many epithelial cells, including those of the kidney, gut and conducting airways. Mutation of the gene encoding CFTR is the primary defect in cystic fibrosis, a disease that affects approximately 30 000 individuals in the United States alone. Alteration of CFTR function also plays an important role in the pathophysiology of secretory diarrhea and polycystic kidney disease. The basic mechanisms of permeation in this channel are not well understood. It is not known which portions of the protein contribute to forming the pore or which amino acid residues in those domains are involved in the biophysical processes of ion permeation. In this review, I will discuss (i) the present understanding of ion transport processes in the wild-type CFTR channel, (ii) the experimental approaches currently being applied to investigate the pore, and (iii) a proposed structure that takes into account the present data on mechanisms of ion selectivity in the CFTR channel and on blockade of the pore by open-channel blockers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10851114     DOI: 10.1242/jeb.203.13.1947

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  37 in total

1.  Molecular determinants of Au(CN)(2)(-) binding and permeability within the cystic fibrosis transmembrane conductance regulator Cl(-) channel pore.

Authors:  Xiandi Gong; Susan M Burbridge; Elizabeth A Cowley; Paul Linsdell
Journal:  J Physiol       Date:  2002-04-01       Impact factor: 5.182

2.  Differential contribution of TM6 and TM12 to the pore of CFTR identified by three sulfonylurea-based blockers.

Authors:  Guiying Cui; Binlin Song; Hussein W Turki; Nael A McCarty
Journal:  Pflugers Arch       Date:  2011-12-13       Impact factor: 3.657

3.  Time-dependent interactions of glibenclamide with CFTR: kinetically complex block of macroscopic currents.

Authors:  Z-R Zhang; G Cui; S Zeltwanger; N A McCarty
Journal:  J Membr Biol       Date:  2004-10-01       Impact factor: 1.843

4.  Changes in accessibility of cytoplasmic substances to the pore associated with activation of the cystic fibrosis transmembrane conductance regulator chloride channel.

Authors:  Yassine El Hiani; Paul Linsdell
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

5.  Requirements for efficient correction of ΔF508 CFTR revealed by analyses of evolved sequences.

Authors:  Juan L Mendoza; André Schmidt; Qin Li; Emmanuel Nuvaga; Tyler Barrett; Robert J Bridges; Andrew P Feranchak; Chad A Brautigam; Philip J Thomas
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

6.  Divergent CFTR orthologs respond differently to the channel inhibitors CFTRinh-172, glibenclamide, and GlyH-101.

Authors:  Maximilian Stahl; Klaus Stahl; Marie B Brubacher; John N Forrest
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-21       Impact factor: 4.249

7.  Molecular determinants and role of an anion binding site in the external mouth of the CFTR chloride channel pore.

Authors:  Xiandi Gong; Paul Linsdell
Journal:  J Physiol       Date:  2003-04-04       Impact factor: 5.182

8.  Molecular and functional characterization of the cystic fibrosis transmembrane conductance regulator from the Australian common brushtail possum, Trichosurus vulpecula.

Authors:  K J Demmers; D Carter; S Fan; P Mao; N J Maqbool; B J McLeod; R Bartolo; A G Butt
Journal:  J Comp Physiol B       Date:  2009-12-12       Impact factor: 2.200

9.  Enteric oxalate secretion is not directly mediated by the human CFTR chloride channel.

Authors:  Robert W Freel; Marguerite Hatch
Journal:  Urol Res       Date:  2008-06-18

10.  Regulation of conductance by the number of fixed positive charges in the intracellular vestibule of the CFTR chloride channel pore.

Authors:  Jing-Jun Zhou; Man-Song Li; Jiansong Qi; Paul Linsdell
Journal:  J Gen Physiol       Date:  2010-02-08       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.